AARP Eye Center
Get ready for your Part D premiums to escalate -
KFF.org - 04/24/2024 - A New Use Opens the Door for Medicare Coverage for MILLIONS
from the link ~ lots more at the link too
The FDA recently approved a new use for Wegovy (semaglutide), the blockbuster anti-obesity drug, to reduce the risk of heart attacks and stroke in people with cardiovascular disease who are overweight or obese. Wegovy belongs to a class of medications called GLP-1 (glucagon-like peptide-1) agonists that were initially approved to treat type 2 diabetes but are also highly effective anti-obesity drugs. The new FDA-approved indication for Wegovy paves the way for Medicare coverage of this drug and broader coverage by other insurers. Medicare is currently prohibited by law from covering Wegovy and other medications when used specifically for obesity. However, semaglutide is covered by Medicare as a treatment for diabetes, branded as Ozempic.
If you have United Healthcare insurance, good luck with them covering it. They won't cover Ozempic which worked for my diabetes and I've tried their approved Trulicity and Bydureon with no luck. Have tried to get a tier reduction but still can't afford the 40% co-pay. And, just try calling in--always a non-helpful foreign speaking customer service who reads an answer out of a book. Why AARP is in bed with United Healthcare as they care more about their shareholders than customers.
One of the reasons why a beneficiary can change their
EVERY YEAR during open enrollment is because our healthcare needs do change, Thus a beneficiary needs to find the best plan to fit their needs in prescription drugs and medical needs.
Open enrollment starts October 15 for plans to be effective for January 01 of the next year.
Medicare.gov - The Basics - Enrollment periods
You should be able to find this specific med on another Med D plan if it is what you need rather than another one of the GLP-1 meds.
"I downloaded AARP Perks to assist in staying connected and never missing out on a discount!" -LeeshaD341679